Abstract
SUMMARYMost of the benefit of asthma preventer inhalers is seen with low doses. However, many Australian patients are prescribed doses of inhaled corticosteroids that are higher than necessary to control their asthma.Prescribing unnecessarily high preventer doses increases the patient’s risk of adverse effects. They may also increase the patient’s out-of-pocket costs.Asthma guidelines recommend considering a step-down in preventer treatment after asthma has been well controlled for two to three months in adults and for six months in children. The step-down process should be individualised for each patient.Preventive therapy should not be stopped completely.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
